More Globe Newswire

View Older Stories View Newer Stories

Nov 4, 2026 04:05PM XBP Global Schedules Conference Call for Third Quarter 2026 Financial Results
Nov 4, 2026 04:05PM Myriad Genetics Reports Third Quarter 2026 Financial Results; Raises Mid-Point of Full-Year 2026 Revenue Guidance Following Solid Execution Definitive Agreement to Sell Prenatal Health Business to Sup
Nov 4, 2026 04:05PM Ormat Technologies Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:05PM Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:05PM Vaxcyte Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 4, 2026 04:05PM PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
Nov 4, 2026 04:05PM Remitly Reports Record Third Quarter Results and Raises Full Year 2026 Outlook
Nov 4, 2026 04:05PM BBSI Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:05PM Encore Capital Group Announces Third Quarter 2026 Financial Results
Nov 4, 2026 04:05PM Veracyte Announces Third Quarter 2026 Financial Results
Nov 4, 2026 04:05PM Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates
Nov 4, 2026 04:05PM ThredUp Announces Third Quarter 2026 Results
Nov 4, 2026 04:05PM Gold.com Reports Fiscal First Quarter 2027 Results
Nov 4, 2026 04:05PM Nasdaq Reports October 2026 Volumes
Nov 4, 2026 04:05PM ADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 4, 2026 04:05PM red violet Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:05PM Interparfums, Inc. Reports 2026 Third Quarter and Nine-Month Results; Raises Full Year Sales Guidance and Reaffirms Earnings Outlook
Nov 4, 2026 04:05PM Lesaka Delivers Q1 FY2027 Results in Line with Expectations, Reaffirms FY2027 Guidance
Nov 4, 2026 04:05PM Silvaco Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:05PM Robinhood Markets, Inc. to Present at the Wolfe Research Wealth Symposium on November 11, 2026
Nov 4, 2026 04:05PM Coherent Corp. Reports First Quarter Fiscal 2027 Results
Nov 4, 2026 04:05PM EverQuote to Present at Upcoming Investor Conferences
Nov 4, 2026 04:05PM Immuneering to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
Nov 4, 2026 04:05PM Agomab to Participate in Upcoming Investor Conferences
Nov 4, 2026 04:03PM Vertex Announces Third Quarter 2026 Financial Results
Nov 4, 2026 04:02PM Green Thumb Industries Reports Third Quarter 2026 Results
Nov 4, 2026 04:02PM Revolution Medicines Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
Nov 4, 2026 04:02PM Veeco Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:02PM Baird Medical Issues Statement Regarding Recent Share Price Volatility
Nov 4, 2026 04:02PM HMH Holding Inc. Announces Third Quarter 2026 Results
Nov 4, 2026 04:01PM Stellantis Appoints Pablo Di Si Chief Operating Officer, North America and American Brands
Nov 4, 2026 04:01PM Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 2026 Financial Results
Nov 4, 2026 04:01PM LegalZoom Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:01PM Lumine Group Inc. Announces Results for the Third Quarter Ended September 30, 2026
Nov 4, 2026 04:01PM Celldex to Present at Upcoming Investor Conferences
Nov 4, 2026 04:01PM Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 4, 2026 04:01PM Asure Software Sets November and December 2026 Investor Conference Schedule
Nov 4, 2026 04:01PM BioCryst to Present at Upcoming Investor Conferences
Nov 4, 2026 04:01PM PureCycle Technologies Reports Third Quarter 2026 Results
Nov 4, 2026 04:01PM Oxford Lane Capital Corp. Announces Full Redemption of 5.00% Notes Due 2027
Nov 4, 2026 04:01PM Progyny, Inc. Announces Third Quarter 2026 Results
Nov 4, 2026 04:01PM Sunrun Reports Third Quarter 2026 Financial Results
Nov 4, 2026 04:01PM Baird Medical Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Nov 4, 2026 04:01PM Olema Oncology to Present Combination Data from the Palazestrant and OP-3136 Programs at the 2026 San Antonio Breast Cancer Symposium
Nov 4, 2026 04:01PM Arvinas to Present Preliminary Clinical Data from Early Monotherapy Dose Escalation Cohorts in the Phase 1 Trial for ARV-393 (Zaloblideg), a PROTAC BCL6 Degrader, at the 2026 American Society of Hemat
Nov 4, 2026 04:01PM Sezzle Reports Third Quarter 2026 Results
Nov 4, 2026 04:01PM Global Water Resources Receives ACC Approval for Rate Increase for GW-Santa Cruz
Nov 4, 2026 04:01PM Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 4, 2026 04:01PM Design Therapeutics Announces Third Quarter 2026 Financial Results and Recent Business Updates
Nov 4, 2026 04:01PM ARKO Petroleum Corp. Reports Third Quarter 2026 Results, Raises Full Year 2026 Guidance and Declares Quarterly Dividend
View Newer Stories View Older Stories